Imperial College London

Imperial College London

Drug Discovery and Development (Multidisciplinary Science for Next Generation Therapeutics)

This programme provides an understanding of the current global state of drug discovery together with insights into future directions. Students gain knowledge of the drug discovery process from emerging technologies and drug target selection through to clinical trials and regulatory aspects, and are challenged to develop their own ideas on how to focus academic and industrial research to meet the pressing challenges of drug discovery.

Entry requirements

A 1st or Upper 2nd Class Honours degree in a relevant subject, particularly chemistry, pharmacy, physics, biochemistry or medicine. Applicants whose 1st language is not English should have an IELTS score of 7.0 overall (minimum 6.5 in all elements) or equivalent qualification.

Course modules

Modules include: Standard drug discovery model; small molecule drugs; biologicals; molecular interactions in proteins and enzymes; what makes a good drug: overview on target validation; systems approaches in drug discovery; chemical genetics; target selection and biomarkers; protein modelling strategies: the right drugs - in silico drug design; structural biology for drug design; bioanalytical techniques; high throughput screening; high content screening; re-purposing drugs; fragment-based drug design; whole animal imaging; gene therapy; getting drugs to market; financing and protecting drug discovery.


Qualification Study mode Start month Fee Course duration
MRes Full-time £ 10,450 per Academic year (home fees) 1 years
MRes Full-time £ 29,300 per Academic year (overseas fees) 1 years

Campus details

Campus name Town Postcode Region Main campus Campus Partner
South Kensington Campus Kensington and Chelsea SW7 2AZ South East

Key information

Telephone number: 
020 7594 5864